|
Back to Women and Heart Disease main page
51. Goldenberg I, Jonas M, Tenenbaum A, et al. Current smoking, smoking cessation, and the risk of sudden cardiac death in patients with coronary artery disease. Arch Intern Med. 2003;163:2301-2305.
52. Bairey Merz N. Assessment of patients at intermediate cardiac risk. Am J Cardiol. 2005;96(suppl):2J-10J.
53. Grundy SM, Cleeman JI, Bairey Merz CN, et al. Implications of recent trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation. 2004;110:227-239.
54. Mosca L, Appel LJ, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation. 2004;109:672-693.
55. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499-511.
56. Khera A, McGuire DK, Murphy SA, et al. Race and Gender differences in C-reactive protein levels. J Am Coll Cardiol. 2005;46:464-469.
57. Heald CL, Fowkes FG, Murray GD, Price JF. Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis. April 16, 2006. (Published online ahead of print.)
58. Albright CL, Cohen S, Gibbons L, et al. Incorporating physical activity advice into primary care: physician-delivered advice within the Activity Counseling Trial. Am J Prev Med. 2000;18:225-234.
59. McInnis KJ, Franklin BA, Rippe JM. Counseling for physical activity in overweight and obese patients. Am Fam Physician. 2003;67:1249-1256, 1266-1288.
60. Tormey SM, Malone CM, McDermott EW, O'Higgins NJ, Hill AD. Current status of combined hormone replacement therapy in clinical practice. Clin Breast Cancer. 2006;6(suppl 2):S51-S57.
61. Gibbons RJ, Chatterjee K, Daley J, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol. 1999;33:2092-2197.
62. Raggi P. Role of electron-beam computed tomography and nuclear stress testing in cardiovascular risk assessment. Am J Cardiol. 2005;96(suppl):20J-27J.
63. Escolar E, Weigold G, Fuisz A, Weissman NJ. New imaging techniques for diagnosing coronary artery disease. Can Med Assoc J. 2006;174:487-495.
64. Gulati M, Pandey DK, Arnsdorf MF, et al. Exercise capacity and the risk of death in women: the St James Women Take Heart Project. Circulation. 2003;108:1554-1559.
65. Senior R, Monaghan M, Becher H, Mayet J, Nihoyannopoulos P. Stress echocardiography for the diagnosis and risk stratification of patients with suspected or known coronary artery disease: a critical appraisal. Heart. 2005;91:427-436.
66. Cuocolo A, Acampa W, Imbriaco M, De Luca N, Iovino GI, Salvatore M. The many ways to myocardial perfusion imaging. Q J Nucl Med Mol Imaging. 2005;49:4-18.
67. Gould KL. Positron emission tomography in the routine management of coronary artery disease. Business Briefing: US Cardiology. 2006:122-128. Available at: http://www.touchcardiology.com/articles.cfm?article_id=552&level=2.
68. Gulati M, McBride PE. Functional capacity and cardiovascular assessment: submaximal exercise testing and hidden candidates for pharmacologic stress. Am J Cardiol. 2005;96(suppl):11J-19J.
69. Hendel RC, Bateman TM, Cerqueira MD, et al. Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol. 2005;46:2069-2075.
70. Cerqueira MD. Pharmacologic stress versus maximal-exercise stress for perfusion imaging: which, when, and why? J Nucl Cardiol. 1996;3:S10-S14.
71. Bar Harbor Invitation Meeting 2000. J Nucl Cardiol. 2001;8:224-316.
72. Darrow MD. Ordering and understanding the exercise stress test. Am Fam Physician. 1999;59:401-410.
73. The Myocardial Perfusion Study Monthly Monitor. Malvern, Pa: Arlington Medical Resources Inc; 2005.
74. Levine MG, Ahlberg AW, Mann A, et al. Comparison of exercise, dipyridamole, adenosine, and dobutamine stress with the use of Tc-99m tetrofosmin tomographic imaging. J Nucl Cardiol. 1999;6:389-396.
75. Nishimura S, Mahmarian JJ, Boyce TM, Verani MS. Equivalence between adenosine and exercise thallium-201 myocardial tomography: a multicenter, prospective, crossover trial. J Am Coll Cardiol. 1992;20:265-275.
References 76-133
|
